Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
The present study has evaluated the protection conferred by a single subcutaneous dose of a modified vaccinia virus Ankara (MVA) vectored vaccine encoding the Rift Valley Fever virus (RVFV) glycoproteins Gn and Gc in lambs. Three groups of six to seven lambs were immunized as follows: one group rece...
Hlavní autoři: | Busquets, N, Lorenzo, G, López-Gil, E, Rivas, R, Solanes, D, Galindo-Cardiel, I, Abad, F, Rodríguez, F, Bensaid, A, Warimwe, G, Gilbert, S, Domingo, M, Brun, A |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Elsevier
2014
|
Podobné jednotky
-
Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs
Autor: Busquets, N, a další
Vydáno: (2014) -
Evaluation of the protective potential of a recombinant modified vaccinia virus Ankara (MVA) encoding rift valley fever virus (RVFV) glycoproteins in lambs
Autor: Busquets, N, a další
Vydáno: (2011) -
Rift Valley fever: biology and epidemiology
Autor: Wright, D, a další
Vydáno: (2019) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
Autor: Warimwe, G, a další
Vydáno: (2013) -
MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
Autor: Elena López-Gil, a další
Vydáno: (2020-02-01)